Skip to content
Subscriber Only

Roche Extends Illumina Bid Again Before Meeting Vote

Roche Holding AG extended its $5.7 billion hostile takeover offer for Illumina Inc. for a second time, setting up a showdown next month at the annual meeting of the U.S. maker of gene-mapping tools.

Shareholders will have until 6 p.m. New York time on April 20 to tender their stock at $44.50 a share, Basel, Switzerland-based Roche said in a statement today. The offer had been set to expire at 6 p.m. New York time March 23. Illumina shares are trading 13 percent above the bid, indicating stockholders expect a higher price.